Scientists have developed a new eyedrop that can ferry protective compounds all the way to the retina, paving the way for a ...

Use of metformin does not appear to be associated with the development or progression of age-related macular degeneration, a ...

An mRNA vaccine developed by researchers from Japan suppressed abnormal blood vessel growth or neovascularization in the ...

If your vision is blurry or fuzzy, or if you notice that straight lines appear curved or wavy, they could be symptoms of ...

In the United States, age-related macular degeneration is a leading cause of irreversible vision loss in people who are 60 ...

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) focused on one condition or the other, retina specialists commonly encounter ...

IRON MOUNTAIN — Garrett Eye Center in Iron Mountain is offering a new non-invasive treatment for early stage dry macular ...

The FDA has granted Fast Track Designation to Sanofi’s SAR402663, an investigational one-time intravitreal gene therapy for neovascular age-related macular degeneration (AMD). The action could ...

Age-related macular degeneration is a leading cause of blindness and affects over 196 million people worldwide. Despite its prevalence, very little is known about the causes or mechanisms of this ...

The global macular edema and macular degeneration market size is calculated at USD 11.90 billion in 2025 and is expected to ...